Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HAO | ANNUAL REPORT......any thoughts? | 28/04/24 | 1 | 123 | |||
|
|||||||
HAO | CAI TH | 24/04/24 | 14 | 2.8K | |||
|
|||||||
HAO | Share Purchase Offer | 19/03/24 | 19 | 5.2K | |||
|
|||||||
HAO | ASX Re-listing | 31/10/23 | 1 | 557 | |||
|
|||||||
HAO | Capital restructure | 27/09/23 | 13 | 3.1K | |||
|
|||||||
HAO | Maybe good things will finally happen? | 21/08/23 | 15 | 3.4K | |||
|
|||||||
HAO | No Buyers | 14/08/23 | 2 | 754 | |||
|
|||||||
HAO | Calidus Announcement June 2023 | 27/06/23 | 3 | 1.1K | |||
|
See All Discussions